United States Renal Data System Coordinating Center, 914 South 8th Street, Minneapolis, MN 55404, USA.
Kidney Int. 2010 Jan;77(2):141-51. doi: 10.1038/ki.2009.413. Epub 2009 Nov 11.
Since comorbid conditions are highly prevalent among patients with end-stage renal disease, indexes measuring them have been widely used to describe the comorbidity burden and to predict outcomes as well as adjust for their roles as confounders. The current comorbidity indexes, however, were developed for general populations or on small patient cohorts. In this study we developed a new index for mortality analyses of dialysis patients based on the 2000 US incident dialysis population, and validated this using the 1999 and 2001 incident and 2000 prevalent dialysis patient populations. Numerical weights were assigned to the comorbid conditions of atherosclerotic heart disease, congestive heart failure, cerebrovascular accident/transient ischemic attack, peripheral vascular disease, dysrhythmia, other cardiac diseases, chronic obstructive pulmonary disease, gastrointestinal bleeding, liver disease, cancer, and diabetes. A patient's comorbidity score was the sum of the weights corresponding to the individual conditions present and could be used as a continuous variable in analyses. Our index performance was almost identical to the individual comorbid conditions regarding model fit, predictive ability, and effect on inference, and it outperformed the widely used Charlson Comorbidity Index.
由于患有终末期肾病的患者常合并多种疾病,因此已经广泛应用各种指标来描述其合并症负担,并预测预后,同时还可以将其作为混杂因素进行校正。然而,目前的合并症指数是为一般人群或小患者队列开发的。在这项研究中,我们基于 2000 年美国新发生的透析患者人群,为透析患者的死亡率分析开发了一种新的指数,并使用 1999 年、2001 年新发生的透析患者和 2000 年现患透析患者人群对其进行了验证。我们为动脉粥样硬化性心脏病、充血性心力衰竭、脑血管意外/短暂性脑缺血发作、外周血管疾病、心律失常、其他心脏疾病、慢性阻塞性肺疾病、胃肠道出血、肝脏疾病、癌症和糖尿病等合并症分配了数值权重。患者的合并症评分是存在的个体疾病权重的总和,可以作为分析中的连续变量使用。我们的指数在模型拟合、预测能力和对推断的影响方面与单个合并症几乎相同,而且优于广泛使用的 Charlson 合并症指数。